Immunome, Inc.

Immunome, Inc.

生物技术研究

Bothell,Washington 6,853 位关注者

Developing antibody-based therapeutics by unlocking the human memory B cell response.

关于我们

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.

网站
https://www.immunome.com/
所属行业
生物技术研究
规模
51-200 人
总部
Bothell,Washington
类型
上市公司
创立
2008
领域
immunotherapy、biotechnology和antigen discovery

地点

  • 主要

    18702 North Creek Pkwy

    100

    US,Washington,Bothell,98011

    获取路线
  • 665 Stockton Drive

    Suite 300

    US,PA,Exton,19341

    获取路线

Immunome, Inc.员工

动态

相似主页

查看职位

融资

Immunome, Inc. 共 20 轮

上一轮

上市后股权

US$230,000,000.00

Crunchbase 上查看更多信息